Accuray (ARAY) Other Non-Current Liabilities (2011 - 2026)
Accuray's (ARAY) quarterly Other Non-Current Liabilities came in at $6.9 million in Q1 2026, up 13.02% year-on-year from $6.1 million in Q1 2025, and up 13.51% quarter-over-quarter from $6.1 million in Q4 2025.
Accuray (ARAY) Other Non-Current Liabilities (2011 - 2026) Analysis & Trends
Accuray's Other Non-Current Liabilities history runs 16 years deep, the most recent figure standing at $6.9 million for Q1 2026.
- On a quarterly basis, Other Non-Current Liabilities rose 13.02% year-over-year to $6.9 million in Q1 2026; TTM through Mar 2026 was $6.9 million, a 13.02% increase from a year earlier, with the FY2025 full-year figure at $5.2 million, down 30.17% from the prior year.
- Other Non-Current Liabilities advanced to $6.9 million in Q1 2026 per ARAY's latest filing, from $6.1 million in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $7.4 million in Q2 2024 and bottomed at $3.6 million in Q3 2022.
- The 5-year median for Other Non-Current Liabilities is $5.3 million (2022), against an average of $5.6 million.
- Across the five-year window, Other Non-Current Liabilities sank 53.72% in 2022 and soared 49.69% in 2024, its largest moves.
- Year by year, Other Non-Current Liabilities stood at $5.2 million in 2022, then declined by 7.28% to $4.8 million in 2023, then rose by 25.1% to $6.0 million in 2024, then gained by 1.51% to $6.1 million in 2025, then grew by 13.51% to $6.9 million in 2026.
- Per Business Quant, the three latest ARAY Other Non-Current Liabilities figures stand at $6.9 million (Q1 2026), $6.1 million (Q4 2025), and $5.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Accuray | 29,832.96 | -38.50 Mn | 25.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.93 Mn |
| Dec 31, 2025 | 6.10 Mn |
| Sep 30, 2025 | 5.35 Mn |
| Jun 30, 2025 | 5.16 Mn |
| Mar 31, 2025 | 6.13 Mn |
| Dec 31, 2024 | 6.01 Mn |
| Sep 30, 2024 | 7.34 Mn |
| Jun 30, 2024 | 7.39 Mn |
| Mar 31, 2024 | 4.97 Mn |
| Dec 31, 2023 | 4.80 Mn |
| Sep 30, 2023 | 4.90 Mn |
| Mar 31, 2023 | 4.64 Mn |
| Dec 31, 2022 | 5.18 Mn |
| Sep 30, 2022 | 3.63 Mn |
| Jun 30, 2022 | 3.75 Mn |
| Mar 31, 2022 | 6.81 Mn |
| Dec 31, 2021 | 6.70 Mn |
| Sep 30, 2021 | 7.84 Mn |
| Jun 30, 2021 | 7.77 Mn |
| Mar 31, 2021 | 8.95 Mn |